Differences

This shows you the differences between two versions of the page.

--- documentation:oncology:meeting_notes_2019_jun-11 [2019/06/12 14:28] – mgurley
+++ documentation:oncology:meeting_notes_2019_jun-11 [2019/08/18 13:31] (current) – mgurley
@@ Line 1: / Line 1: @@
+**Meeting Notes June 11, 2019**
 **Topics**
-* The group reviewed the following presentation:
+  * The group reviewed the following presentation:
 {{:documentation:oncology:ohdsi_oncology_meeting_06_11_2019.pdf| Presentation}}
-* The group discussed SQL showing to map ICDO Site/Histology combinations to per-coordinated Condition concepts.
-* The group discussed SQL showing how to find all Site/Histology combinations containing a particular ICDO site or histology.
+  * The group discussed SQL showing how to map ICDO Site/Histology combinations to pre-coordinated Condition concepts.
-* It was announced that ICDO is currently already implemented within Athena and folks should try mapping their ICDO data.
-* The group discussed the plan to adopt NAACCR as OMOPS's standard vocabulary of cancer diagnosis modifiers and the plant to transition NAACCR from a standard vocabulary to source vocabulary by mapping NAACCR to the Nebraska Lexicon.
+  * The group discussed SQL showing how to find all Site/Histology combinations containing a particular ICDO site or histology.
-* Concern was expressed regarding the timeline for when the Nebraska Lexicon would be completed.
-* There was consensus in the group that the OMOP community needs to standardize the representation of cancer  diagnosis modifiers.  Some members of the group might take a swipe at recommending cancer diagnosis modifiers ahead of the Nebraska Lexicon completion date.
+  * It was announced that ICDO is currently already implemented within Athena and folks should try mapping their ICDO data.
-* It was announced that the Hemonc.org drug regimen ontology has been released within Athena.
-* The group discussed the current state the Hemonc.org vocabulary.  Regimens and regiment components mapped to RxNorm ingredients.  Plus a better drug oncology classification system.
+  * The group discussed the plan to adopt NAACCR as OMOPS's standard vocabulary of cancer diagnosis modifiers and the plant to transition NAACCR from a standard vocabulary to source vocabulary by mapping NAACCR to the Nebraska Lexicon.
-* The group asked about the future possibility of including regimen dosing, cycles and indications.  Dmytry informed the group that these items would be part of future releases.
+  * Concern was expressed regarding the timeline for when the Nebraska Lexicon would be completed.
+  * There was consensus in the group that the OMOP community needs to standardize the representation of cancer  diagnosis modifiers.  Some members of the group might take a swipe at recommending cancer diagnosis modifiers ahead of the Nebraska Lexicon completion date.
+  * It was announced that the Hemonc.org drug regimen ontology has been released within Athena.
+  * The group discussed the current state of the Hemonc.org vocabulary.  Regimens and regimen components mapped to RxNorm ingredients.  Plus a better drug oncology classification system.
+  * The group asked about the future possibility of including regimen dosing, cycles and indications.  Dmytry informed the group that these items would be part of future releases.